Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134209 · ClinicalTrials.gov registry record · NA
A Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications
A NA study of Joint Disease and Arthropathy, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT03134209: Completed NA study of Joint Disease and Arthropathy, sponsored by NYU Langone Health.
NCT03134209 is a NA study of Joint Disease and Arthropathy that has completed, run by NYU Langone Health. The registered enrollment target is 160 participants, above the 132-participant average among 4 other Joint Disease trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03134209, a NA study of Joint Disease and Arthropathy, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
A single-center, phase IV, randomized, prospective study investigating the efficacy of various wound closure devices in reducing postoperative wound complications.
Primary Outcome
The visual analog scale (VAS) is a tool widely used to measure pain. A patient is asked to indicate his/her perceived pain intensity along a horizontal line, and this rating is then measured from the left edge. The total range of score is 0-10; the higher the score the worse the pain (0 = no pain, 10 = worst pain imaginable).
Conditions Studied
Interventions
- DEVICE Zipper surgical skin closure
- OTHER Monocryl + Dermabond
- OTHER Polyester mesh + Dermabond
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-04-26 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
What the finished NCT03134209 record still lists
NCT03134209 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 4 other Joint Disease trials with a reported enrollment target (21% higher).
The record links to 2 conditions, with Joint Disease appearing as the primary indexed condition, and to 3 interventions - of which Zipper surgical skin closure is the first listed.
NCT03134209 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03134209 about?
NCT03134209 is a clinical study titled "A Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications". A single-center, phase IV, randomized, prospective study investigating the efficacy of various wound closure devices in reducing postoperative wound complications.
What is the current status of trial NCT03134209?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2017-04-26. Estimated completion is 2020-08-31.
What conditions does trial NCT03134209 study?
This clinical trial studies the following conditions: Joint Disease, Arthropathy.
What interventions are being tested in trial NCT03134209?
The interventions under investigation include: Zipper surgical skin closure (DEVICE), Monocryl + Dermabond (OTHER), Polyester mesh + Dermabond (OTHER).
Who is sponsoring clinical trial NCT03134209?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03134209 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Joint Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comprehensive Shoulder System Nano IDE
COMPLETED · NA
-
Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts
ACTIVE NOT RECRUITING
-
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
COMPLETED · Phase 2
-
Quantitative Gait Analysis for Clinical Decision Making
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI